NEXCEA LIMITED
Company number 12542772 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£2,262
Balance sheet as at 2025-04-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-04-01
- Employees
- 3 (2025 accounts · was 2 in 2024)
- Registered office
- Adamson House, Wilmslow Road, Manchester, England, M20 2YY
- Postcode
- M20 2YY
- Capital
- 1 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-04-30
- Next due by
- 2027-01-31
- Financial year end
- 30 April
Confirmation statement
- Last statement dated
- 2026-03-31
- Next due by
- 2027-04-14
Nature of business (SIC)
- 70229 Management consultancy activities other than financial management
- 71122 Engineering related scientific and technical consulting activities
- 73200 Market research and public opinion polling
- 86900 Other human health activities
Officers 1 current
Public contracts won 1
£25,650 total awarded value where published.
Contains public sector information licensed under the Open Government Licence v3.0 (Contracts Finder).
Contact details
- Website
- nexcea.com
Nexcea is a life sciences consultancy. We support clients through our core capabilities of strategy development, stakeholder engagement, market research, launch and commercialisation, and medical and scientific communications. Client sectors include pharma and medical devices, healthcare organisatio
Previous company names
| Name | Date changed |
|---|---|
| GLASSHOUSE HEALTH LIMITED | 2024-06-03 |
| HEALTH INSIGHTS & GUIDANCE LIMITED | 2021-06-08 |
At this address
Among the biggest employers
of 1,718 similar companies in M, with 3 staff.
Competitors Manchester
This company ranks 1322 among management consultancy activities other than financial management in Manchester.
The class of 2020
38%
of the 27,973 companies in this sector incorporated in 2020 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.